1. Analyst View
2. Global Pharmaceutical Market
2.1 Geographical Performance
2.2 Leading Therapy Classes
2.3 Leading Companies
2.4 Leading Drugs
3. Russia - Demographics & Healthcare Profile
3.1 Life Expectancy
3.2 Age Breakup
3.3 Hospital Beds & Doctors
3.4 Healthcare Expenditure
4. Pharmaceutical Market
4.1 Market Size & Growth
4.2 Comparative Analysis
4.3 Commercial Drugs Market
4.3.1 Trends
4.3.2 Imported & Domestic Drugs
4.3.3 RX & OTC Drugs
4.3.4 Sales Structure - By ATC Groups
4.3.5 Leading Companies
4.3.6 Leading Drugs
4.3.7 Price Analysis
4.4 State Segment
4.4.1 DLO Reimbursement Programme
4.4.1.1 Imported & Domestic Drugs
4.4.1.2 RX & OTC Drugs
4.4.1.3 Sales Structure - By ATC Groups
4.4.1.4 Leading Companies
4.4.1.5 Leading Drugs
4.4.2 Hospital Segment
4.4.2.1 Imported & Domestic Drugs
4.4.2.2 Leading Companies
4.4.2.3 Leading Drugs
4.4.2.4 Drugs Demand - By Price
4.5 Parapharmaceutical Market
4.5.1 Nutritional Supplements Market
4.5.1.1 Imported & Domestic Supplements
4.5.1.2 Leading Supplements
4.5.1.3 Supplement Demand - By Price
4.6 New Drugs
5. Industry Analysis
5.1 Market Driving Forces
5.1.1 Aging Population
5.1.2 Increasing Volume & Sales of Expensive Drugs
5.1.3 Government Support & Funding
5.1.4 Medical Insurance
5.1.5 Growing Disposable Income
5.2 Growth Avenues
5.2.1 Cardiovascular Drugs
5.2.2 HIV Drugs
5.2.3 High Insulin Demand
5.2.4 Cancer Drugs
5.2.5 Foreign Players
5.2.6 Generics
5.2.7 Clinical Trials Market
5.3 Market Roadblocks
5.3.1 Declining Population
5.3.2 Low Growth in Spending under DLO Programme
5.3.3 Price Control
5.3.4 Drug Counterfeiting & Weak IPR Regime
6. Future Outlook (2008-2012)
6.1 Commercial Drugs Market
6.2 State Segment
6.3 Parapharmaceutical Market
7. Key Players
7.1 Sanofi-Aventis
7.2 Novartis International AG
7.3 Roche Group
7.4 Pfizer Inc
7.5 AstraZeneca Plc
